Wednesday, May 13, 2015 11:24:59 AM
I'll preference this by saying that I'm generally biased against non-GAAP measures. However, in the case of MSLP, I think that bias is very justified. The non-GAAP EBITDA figure is a particularly bad metric for analysis the stock's potential, because the company is actively diluting. In addition to the excessive, stock-based executive compensation, they paid for the Coco Protein production and clothing rights in part by issuing something like 300,000 new shares. For the company to then turn around and say, "But if we ignore that dilution, our losses are smaller than they look." is disingenuous and misleading.
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM